Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2009
06/03/2009CN100494179C Novel crystalline of the dehydrated boscalid
06/03/2009CN100494178C Production of pyridil carbonamidine and its salt
06/03/2009CN100494177C Bi-amido heterocyclic derivative with antitumour activity and its preparation method and use
06/03/2009CN100494176C Method for extracting alkali metals or calcium salt of halogen or haloalkyl substituted 2-hydroxy pyridine, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
06/02/2009US7541473 Monocyclopentadienyl complexes
06/02/2009US7541472 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides
06/02/2009US7541469 Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
06/02/2009US7541465 Substituted 2-aminoacetamides and the use thereof
06/02/2009US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases
06/02/2009US7541373 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc.
06/02/2009US7541369 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2009US7541332 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity
06/02/2009CA2434277C Substituted alkylamine derivatives and methods of use
06/02/2009CA2399125C Process for the preparation of 5-arylnicotinaldehydes
05/2009
05/28/2009WO2009067621A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
05/28/2009WO2009067600A2 Biaryl pde4 inhibitors for treating inflammation
05/28/2009WO2009067597A1 4- (or 5-) substituted catechol derivatives
05/28/2009WO2009067406A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
05/28/2009WO2009066060A2 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use
05/28/2009WO2009049180A3 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
05/28/2009WO2009048752A3 Insecticidal substituted azinyl derivatives
05/28/2009WO2009017241A3 Process for producing toluidine compound
05/28/2009WO2008157234A3 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors
05/28/2009WO2008140646A3 Process for the synthesis of cmhtp and intermediates thereof
05/28/2009US20090137834 Levodopa prodrugs, and compositions and uses thereof
05/28/2009US20090137814 Synthesis of diaminodinitropyridine
05/28/2009US20090137811 Process for the preparation of donepezil and intermediate compounds thereof as well as hydrates of donepezil
05/28/2009US20090137808 Process for manufacturing bisphosphonic acids
05/28/2009US20090137806 Dual nk1/nk3 receptor antagonists
05/28/2009US20090137795 New route to formyl-porphyrins
05/28/2009US20090137679 ZN2+Chelating Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase Inhibitors
05/28/2009US20090137640 Potentiator for radiation therapy comprising pyridine derivative as active ingredient
05/28/2009US20090137639 Methods for controlling fungi and bacteria
05/28/2009US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives
05/28/2009US20090137594 Pentafluorosulphanyl-Substituted Compound And Its Use For Producing Medicaments
05/28/2009US20090137587 4-[(4-Chlorobenzyl)oxy]-1-(4-[(1E)-3-(methylamino)-1-propen-1-yl]phenyl)pyridin-2(1H)-one; remedy for metabolic disorders such as obesity, diabetes, hormone disorder; cardiovascular disorders (stenocardia, acute or congestive heart failure); nervous system disorders (bulimia, anxiety, epilepsy etc.)
05/28/2009US20090137585 N-acylsulfonamide apoptosis promoters
05/28/2009US20090137558 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products
05/28/2009US20090136561 Non-peptidyl agents with pHSP20-like activity, and uses thereof
05/28/2009US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
05/28/2009US20090136431 Stilbene Like Compounds as Novel HDAC Inhibitors
05/28/2009US20090134785 Organometallic complex, organic light-emitting element using same, and display device
05/28/2009CA2722611A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
05/28/2009CA2722582A1 Biaryl pde4 inhibitors for treating inflammation
05/27/2009EP2062907A2 Metal coordination compound, luminescence device and display apparatus
05/27/2009EP2062879A1 Heterocyclic inhibitors of p38
05/27/2009EP2062878A1 Hydrazine amide derivative
05/27/2009EP2061790A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
05/27/2009EP2061762A2 Pyrazine compounds, their use and methods of preparation
05/27/2009EP2061761A1 Phenethylamide derivatives with kinase inhibitory activity
05/27/2009EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders
05/27/2009EP2061751A1 Nitrate esters of aminoalcohols
05/27/2009EP1912946B1 Pyridine derivatives as dipeptedyl peptidase inhibitors
05/27/2009EP1866286B1 Pyridine derivatives useful as inhibitors of pkc-theta
05/27/2009EP1694627B1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/27/2009EP1404666B1 4-substituted-picolinic acid amide derivatives useful as fungicides
05/27/2009CN101443006A Novel benzylamine derivatives as CETP inhibitors
05/27/2009CN101440286A Compound polymerization inhibitor and uses thereof
05/27/2009CN101440061A Arylpyridone derivatives with acetylcholine esterase inhibition activity
05/27/2009CN101440060A 2-(4-bromophenyl) pyridine, 4-(2-pyridinyl) phenylo boric acid and synthesizing method thereof
05/27/2009CN101440059A 4-substituted 2,2'-bipyridyl derivatives and synthesizing method thereof
05/27/2009CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors)
05/27/2009CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
05/27/2009CN100491352C Asymmetrical cyclic diamine compound
05/27/2009CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions
05/27/2009CN100491323C Biaryloxymethylarenecarboxylic acids compound
05/26/2009US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
05/26/2009US7538227 admixing with one or more secondary and/or tertiary aliphatic or mixed aliphatic-aromatic amines
05/26/2009US7538224 Such as 2,4-dihydroxy-6-(2-methoxyethyl)phenylphenylketone; antitumor activity; heat shock protein (Hsp) suppression
05/26/2009US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/26/2009US7538127 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation
05/26/2009CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists
05/26/2009CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
05/26/2009CA2434843C Novel couplers for use in oxidative hair dyeing
05/26/2009CA2396587C Pyridine ketone herbicide compositions
05/26/2009CA2396253C Selective electrochemical reduction of halogenated 4-aminopicolinic acids
05/26/2009CA2344058C Diaminopropionic acid derivatives
05/22/2009WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066
05/22/2009WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065
05/22/2009WO2009063054A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
05/22/2009WO2009025820A3 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution
05/22/2009CA2705922A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
05/22/2009CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066
05/21/2009US20090131677 Substituted beta-phenyl-alpha-hydroxy-propanoic acid, synthesis method and use thereof
05/21/2009US20090131489 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/21/2009US20090131486 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
05/21/2009US20090131485 Deuterated pirfenidone
05/21/2009US20090131483 2-pyridine derivatives as inhibitors of neutrophile elastase
05/21/2009US20090131468 Bis-(Sulfonylamino) Derivatives in Therapy 065
05/21/2009US20090131456 Caspase inhibitors and uses thereof
05/21/2009US20090131435 Heterocyclic inhibitors of mek and methods of use
05/21/2009US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease
05/21/2009US20090131411 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
05/21/2009US20090131256 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane Compounds
05/20/2009EP2060566A1 Poly-substituted aryls
05/20/2009EP2060565A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
05/20/2009EP2060260A1 Therapeutic agents useful for treating pain
05/20/2009EP2059508A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
05/20/2009EP2059507A2 Ep2 agonists